mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.001 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.002 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.005 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.006 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.008 |